- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Barbara Troupin, MD, MBA, Talks about Managing Goals for Obesity Treatment
In this video, Barbara Troupin, MD, MBA, talks about managing goals for obesity treatment. "The goal for obesity treatment is the ability to lose enough weight [to the point where] you actually are addressing the underlying pathophysiology," says Dr Troupin. She goes on to discuss the ideal percentage of weight loss necessary to lose excess adipose tissue.
In this video, Barbara Troupin, MD, MBA, talks about managing goals for obesity treatment.
"The goal for obesity treatment is the ability to lose enough weight [to the point where] you actually are addressing the underlying pathophysiology," says Dr Troupin.
She goes on to discuss the ideal percentage of weight loss necessary to lose excess adipose tissue.
This video was taken on Thursday, October 4, 2012, at the Academy of Managed Care Pharmacy's 2012 Educational Conference in Cincinnati, OH.
Impact of Amivantamab-Lazertinib on EGFR, MET Resistance Alterations in NSCLC: Danny Nguyen, MD
September 15th 2025The combination of amivantamab and lazertinib in first-line non–small cell lung cancer (NSCLC) significantly reduces resistance mechanisms with implications for second-line treatment, said Danny Nguyen, MD, of City of Hope.
Read More
Disparities in Biomarker Testing Impact Nonsquamous NSCLC Outcomes: Surbhi Singhal, MD
September 6th 2025Surbhi Singhal, MD, of the University of California Davis, discussed disparities in biomarker testing among patients diagnosed with stage IV nonsquamous non–small cell lung cancer (NSCLC).
Read More
